Delivery Order SPE2DB20D3103-SPE2DB25FM9V7

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,248.92 firm-fixed-price delivery order covers the supply of Descovy 200-25 mg tablets for an ultimate completion date of November 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $8,961.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug Descovy 200-25 mg tablet, with a completion date of December 12, 2023. The contract is a firm fixed-price type, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $17,370.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that provides the DLA with Descovy 200-25 MG Tablet, a pharmaceutical product, under a Firm Fixed Price pricing arrangement. The contract has an ultimate completion date of January 30, 2025 and does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The order is for the pharmaceutical product Descovy 200-25 mg Tablet, with a ceiling value of $2,153.92 and a completion date of August 29, 2024. As a for-profit pharmaceutical distribution company, Amerisourcebergen is a key vendor for federal...
This federal contract award, valued at $16,941.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Descovy 200-25 mg Tablet, a prescription medication, with a period of performance through March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $17,203.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Descovy 200-25 mg Tablet, a prescription pharmaceutical product, to support defense and federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 14, 2025. The award is not designated under any set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.68 firm-fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET 30S, a prescription medication. The award has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,857.15 firm fixed-price delivery order is for the supply of DESCOVY 200-25 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award is a delivery order valued at $23,792.10 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Descovy 200-25 mg tablets, a prescription medication, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $25,315.91, for the supply of DESCOVY 200-25 MG TABLET. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM9V7
    Delivery Order

This federal contract award, valued at $8,240.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Descovy 200-25 mg tablet, a prescription medication. It has a firm fixed price and an ultimate completion date of March 10, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 6/6/25, 10:03 AM